Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-17 Purchase | 2025-12-08 5:15 pm | DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner | 1,061,277 | $7.1908 | $7,631,469 | 8,825,742 (Indirect) | View |
| 2025-08-13 Purchase | 2025-09-04 2:29 pm | DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner | 1,000,000 | $5.9581 | $5,958,107 | 7,764,465 (Indirect) | View |
| 2025-07-23 Purchase | 2025-07-25 6:54 pm | DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner | 1,542,857 | $3.5 | $5,400,000 | 6,764,465 (Indirect) | View |
| 2025-07-23 Purchase | 2025-07-25 5:49 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEnterprise Private AB 10% Owner | 2,857,142 | $3.5 | $9,999,997 | 8,383,577 (Indirect) | View |
| 2025-07-23 Purchase | 2025-07-25 4:35 pm | DiaMedica Therapeutics Inc. | DMAC | JACINTO RICHARD II 10% Owner | 400,000 | $3.5 | $1,400,000 | 4,958,823 (Indirect) | View |
| 2024-06-28 Purchase | 2024-07-01 4:27 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEnterprise Private AB 10% Owner | 1,200,000 | $2.5 | $3,000,000 | 5,526,435 (Indirect) | View |
| 2024-06-28 Purchase | 2024-07-01 4:24 pm | DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner | 1,200,000 | $2.5 | $3,000,000 | 5,221,608 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-06 5:24 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 10,095 | $8.42 | 97,949 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 5:24 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 6,175 | $8.42 | 445,230 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 5:22 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 3,355 | $8.42 | 47,963 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 4:30 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 12,000 | $2.2 | 87,854 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 4:30 pm | N/A 2025-12-01 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 12,000 | $0 | 87,854 (Direct) | View |
| 2025-08-11 Option Award | 2025-11-03 4:32 pm | N/A 2035-08-10 | DiaMedica Therapeutics Inc. | DMAC | Krop Julie Chief Marketing Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:19 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 250,000 | $0 | 777,114 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:18 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 32,162 | $0 | 76,770 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:18 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President & CEO | 600,000 | $0 | 668,591 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:17 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 40,739 | $0 | 116,593 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:17 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 32,162 | $0 | 32,162 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:16 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director | 32,162 | $0 | 56,372 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:16 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO & Secretary | 225,000 | $0 | 257,290 (Direct) | View |
| 2025-06-01 Option Award | 2025-06-03 4:15 pm | N/A 2035-05-31 | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 32,162 | $0 | 471,217 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-08 4:41 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 24,000 | $2.11 | 312,995 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-08 4:41 pm | N/A 2025-12-01 | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 24,000 | $0 | 312,995 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-24 5:06 pm | N/A 2035-02-19 | DiaMedica Therapeutics Inc. | DMAC | O'Connor Daniel J. Director | 64,242 | $0 | 64,242 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 4:25 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 12,000 | $2.11 | 439,055 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 4:25 pm | N/A 2025-12-01 | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 17,000 | $0 | 439,055 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 4:25 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 5,000 | $3.65 | 439,055 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:46 pm | N/A 2035-01-01 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 4,287 | $0 | 80,141 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:46 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 15,917 | $5.34 | 80,141 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:36 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 10,861 | $5.34 | 422,055 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:28 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director | 9,925 | $5.34 | 24,210 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:23 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 10,393 | $5.34 | 288,995 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:15 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 5,290 | $5.34 | 44,608 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 5:06 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 130,000 | $0 | 657,114 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:59 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary | 130,000 | $0 | 162,290 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:58 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer | 15,000 | $0 | 17,800 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:41 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO | 300,000 | $0 | 368,591 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:35 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 28,472 | $0 | 67,790 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:29 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 36,065 | $0 | 314,667 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:21 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 28,472 | $0 | 88,409 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:14 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 28,472 | $0 | 28,472 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:09 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director | 28,472 | $0 | 42,757 (Direct) | View |
| 2024-06-01 Option Award | 2024-06-03 4:02 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 28,472 | $0 | 439,666 (Direct) | View |